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ABSTRACT: The self-assembly and antimicrobial activity of two novel arginine-capped bola-amphiphile peptides, namely
RA6R and RA9R (R, arginine; A, alanine) are investigated. RA6R does not self-assemble in water due to its high solubility, but
RA9R self-assembles above a critical aggregation concentration into ordered nanoﬁbers due to the high hydrophobicity of the
A9block. The structure of the RA9R nanoﬁbers is studied by cryogenic transmission electron microscopy (cryo-TEM) and small-
angle X-ray scattering (SAXS). Circular dichroism spectroscopy shows that both RA6R and RA9R adopt coil conformations in
water at low concentration, but only RA9R adopts a β-sheet conformation at high concentration. SAXS and diﬀerential scanning
calorimetry are used to study RA6R and RA9R interactions with a mixed lipid membrane that models a bacterial cell wall,
consisting of multilamellar 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol/1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine
vesicles. Cytotoxicity studies show that RA6R is more cytocompatible than RA9R. RA6R has enhanced activity against the
Gram-negative pathogen P. aeruginosa at a concentration where viability of mammalian cells is retained. RA9R has little
antimicrobial activity, independently of concentration. Our results highlight the inﬂuence of the interplay between relative
charge and hydrophobicity on the self-assembly, cytocompatibility, and bioactivity of peptide bola-amphiphiles.
KEYWORDS: peptides, antimicrobial peptides, antibacterials, self-assembly, lipid membranes
■ INTRODUCTION
The increasing occurrence of antibiotic resistant pathogens is
leading to an urgent need to discover or design novel
therapeutics to combat this issue. One important class of
therapeutics is antimicrobial peptides. Antimicrobial peptides
are attractive since many are expressed naturally, and this can
be used as a basis for novel compounds and also due to their
ease of biofunctionalization and biocompatibility.1−3 Many
organisms, for example, fungi, have naturally evolved host
defense antimicrobial peptides, which can be used as actives
themselves, or form the basis of designed synthetic materials.
Antimicrobial peptides with the ability to self-assemble may be
active without the need for carrier molecules.
A class of peptide with strong self-assembly properties are
surfactant-like peptides (SLPs), initially developed by Zhang et
al.4−7 These peptides are short, consisting of a one or two
charged residue headgroup, with a longer hydrophobic
sequence as a tail group. Peptides with various cationic and
anionic headgroups, and diﬀerent hydrophobic amino acid tail
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groups (including alanine, glycine and valine repeat units),
have been studied. Previously our group has studied the
conformation and nanostructure of SLPs including A9R,
8
A6H,
9 A6K,
10 A6R,
11 capA6R,
12 A6RGD,
13 and A6D.
14 Self-
assembly was observed for all of these peptides, above a critical
aggregation concentration (cac), into a variety of structures
including nanosheets, helical ribbons, ﬁbrils, vesicles, nano-
tubes, and nanotapes, with a range of potential applications.
SLPs with cationic head groups have been shown to have
antimicrobial activity.15 A6R was shown to have antimicrobial
activity against E. coli and S. aureus, although interactions with
zwitterionic mammalian lipid membrane model DPPC
(1,2,dipalmitoyl-sn-glycero-3-phosphocholine) did not lead to
breakup of these lipid vesicles.16 Recently, the conformation,
self-assembly, and interactions with lipid membranes were
studied for capA6R, which is capped at both termini (CONH-
AAAAAAR-NH2) to modulate electrostatic interactions.
Interactions with zwitterionic membrane models (POPC/
DOPC) [POPC: 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-
choline, DOPC: 1,2-dioleoyl-sn-glycero-3-phosphocholine]
and mixtures (POPG/POPE) [POPG: 2-oleoyl-1-palmitoyl-
sn-glycero-3-phospho-rac-(1-glycerol) sodium salt, POPE: 2-
oleoyl-1-palmitoyl-sn-glycero-3-phosphoethanolamine] con-
taining the anionic POPG lipid were studied by SAXS and
circular dichroism spectroscopy.12 CapA6R was found to
incorporate into the anionic membrane in a β-sheet
conformation, in contrast to the uncapped peptide A6R
(NH2-AAAAAAR−OH). CapA6R was found to have a strong
selective antimicrobial activity against Listeria monocytogenes,
compared to A6R which shows nonselective activity. SLPs A3K,
A6K, and A9K were shown to assemble into increasingly
ordered structures with increased length of the alanine
hydrophobic motif.15 Interestingly, the antimicrobial activity
of these peptides also increased with the length of the
hydrophobic motif, with A3K showing no antimicrobial
activity, and A6K and A9K showing activity against E. coli
and S.aureus, which are Gram-negative and -positive,
respectively.
Peptide bola-amphiphiles are a class of surfactant-like
peptides. These peptides incorporate a charged residue at
either end of the molecule. The self-assembly behavior of these
SLPs has been investigated. The self-assembly of I2K2I2 and
KI4K has been compared, and it was reported that the former
does not aggregate whereas the latter aggregates into β-sheet
nanotubes.17,18 In another example, the self-assembly ability of
arginine based bola-amphiphile RFL4FR was investigated and
it was found to form nanosheets through lateral association of
the backbone and dried ﬁlms were compatible with human
corneal stromal ﬁbroblast cells.19 Recently our group studied
the self-assembly, antimicrobial activity, and membrane
interaction of a short bola-amphiphile consisting of arginine
and alanine residues, RA3R.
20 RA3R was found to form a
polyproline II (collagen-like) secondary structure, but it does
not assemble in water probably due the solubility imparted by
the R residues. RA3R was found to induce strong correlation
between anionic lipid bilayers through electrostatic interactions
with POPG and demonstrates strong activity against the Gram-
positive foodborne pathogen L. monocytogenes.
Here we investigate the self-assembly of the two peptide
bola-amphiphiles RA6R and RA9R (shown in Scheme 1). This
Scheme 1. Structure of RA6R, RA9R, DPPG, and DPPE
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work follows on from the previous work on RA3R and
investigates the eﬀect of longer hydrophobic alanine motifs on
the self-assembling propensity, interactions with lipid mem-
branes, biocompatibility, and antimicrobial activity. The self-
assembly of RA6R and RA9R is studied in aqueous solution,
and interactions with lipid vesicles DPPG and DPPG/DPPE at
diﬀerent ratios are investigated. In water, DPPG (1,2-
dipalmitoyl-sn-glycero-3-phosphoglycerol) is anionic and
DPPE (1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine) is
zwitterionic (Scheme 1). Phosphoglycerol (PG) and phos-
phoethanolamine (PE) lipids are commonly found in bacterial
cell walls, in contrast to mammalian cell membranes, which
contain a substantial component of phosphocholine (PC) and
PE lipids, but not anionic PG lipids.21−25 Diﬀerent bacteria
species have distinct compositions of PG and PE lipids in their
membranes,26,27 and there are also signiﬁcant membrane
architecture diﬀerences between Gram-positive and Gram-
negative bacteria.28,29 We have selected DPPG/DPPE lipid
mixtures for the present study because both lipids have
accessible melting temperatures (in contrast to POPG used in
our previous studies which has Tm = −2 °C). This lipid system
has been utilized in previous studies on antimicrobial peptide−
membrane interactions.23,30 Finally, we examine the cytocom-
patibility and antimicrobial activity of RA6R and RA9R. In
contrast with the previous study on RA3R,
20 we include an
examination of antibacterial activity against Pseudomonas
species, an important class of animal and plant pathogen.
■ METHODS
Materials. Peptides RA6R and RA9R were supplied by Biomatik
(Cambridge, Ontario, Canada). RA6R purity was 98.86% by HPLC
using an Inertsil ODS-SP column with acetonitrile/water (0.1% TFA)
gradient. RA6R molar mass by ESI-MS was 757.45 g mol
−1 (M+H+,
756.87 g mol−1 expected). RA9R purity was 96.56% by HPLC using
an Inertsil ODS-SP column with acetonitrile/water (0.1% TFA)
gradient. RA9R molar mass by ESI-MS was 970.65 g mol
−1 (M+H+,
970.11 g mol−1 expected). Solutions containing pure peptide in water
were made by dissolving weighed amounts of peptide in water, which
were left to equilibrate for 3 h. The pH was measured as a function of
peptide concentration, and the data are shown in Figure S1. Lipids
DPPG and DPPE were obtained from Sigma-Aldrich. Details of
multilamellar lipid vesicle preparation are given below.
Fluorescence Assays. The presence of any critical aggregation
concentration (cac) was assayed using ﬂuorescence probes, measuring
spectra for a series of peptide concentrations. Fluorescence spectra
were recorded with a Varian Cary Eclipse ﬂuorescence spectrometer
with samples in 4 mm inner width quartz cuvettes. ThT was used to
determine the cac of RA9R, as it is sensitive to the formation of
amyloid ﬁbrils at the cac.31−35 ThT assays were performed using 5.0 ×
10−3 wt % solution to solubilize the peptide. Spectra were recorded
between 460 and 600 (λex = 440 nm). ANS (8-anilinonaphthalene-1-
sulfonic acid) was further used to examine whether there is a cac for
RA6R. ANS is a ﬂuorescent probe used to determine the formation of
molecular hydrophobic environments in solution and can be used to
determine the cac independent from self-assembly into amyloid ﬁbers.
Circular Dichroism (CD) Spectroscopy. CD spectra were
recorded as described previously.8 Samples containing 1 wt % RA6R
or RA9R in pure H2O were pipetted into 0.01 mm path length quartz
plaque cells or 0.1 mm quartz cuvettes.
Fourier Transform Infrared (FTIR) Spectroscopy. Spectra were
recorded as described previously.8 Aliquots containing 80 μL of (1−
5) wt % RA6R or RA9R in D2O were prepared and added to a PEARL
liquid cell.
Cryogenic Transmission Electron Microscopy (Cryo-TEM).
Samples were imaged as described previously.8
Rheology. Measurements were carried out as described
previously.8
Liposome Preparation. Liposome vesicles were prepared using
the thin-layer hydration method. Weighed quantities of DPPG and
DPPE were dissolved in chloroform, and thin lipid ﬁlms were
prepared as described previously.8 After this, lipids were resuspended
in water at 0.5 wt % lipid, heated at 65 °C, above their lipid melting
temperature, Tm, and vortexed for 5 min. Liposome mixtures were
then left to equilibrate for 3 h before experiments. DPPG/DPPE
vesicles were prepared using this method at diﬀerent molar ratios of
1:3, 1:1, 3:1, and 1:0 DPPG:DPPE. Peptide/lipid mixtures were made
by adding enough peptide powder to resuspended lipids to obtain a
ﬁnal concentration of either 0.08 or 0.25 wt % peptide. Peptide/lipid
samples were then heated above the Tm and vortexed for 5 min and
ﬁnally left to equilibrate for 3 h before experiments.
Nano Diﬀerential Scanning Calorimetry (Nano-DSC). Diﬀer-
ential scanning calorimetry measurements were carried out using a
nanoDSC, DSC TA-Q200 instrument. Aliquits of 600 μL of lipid
mixtures at 0.5 wt % with and without 0.08 wt % peptide were
degassed for 10 min before being pipetted into the DSC sample cell.
An amount 600 μL of water was pipetted into the reference cell. The
temperature range measured was 20 to 80 °C for DPPG/DPPE
mixtures and 20 to 60 °C for DPPG alone. The scan rate was 1 °C per
minute at pressure of 3 bar. Background subtraction, main phase
transition temperature, and the transition enthalpy, ΔH, were
calculated using nanoanalyse software.
Small-Angle X-ray Scattering (SAXS). Data from solutions were
collected on the bioSAXS beamlines B21 (Diamond Light Source,
UK) and ID02 (ESRF, Grenoble). At the former, liposome and
peptide samples were loaded into PCR tubes in an automated sample
changer, and measurements were performed as described previously.8
Data were processed using ScÅtter36 and are presented as a function
of q = 4π sin θ/λ. At the ESRF (ID02), 200 μL of sample was
manually loaded into a glass capillary with a 2 mm internal radius.
The beamline operated with λ = 1 Å and a sample−detector distance
1.47 m. The SAXS data from B21 and ID02 were ﬁtted using model
form factors using the software SASﬁt.37 SAXS from hydrogels was
collected on beamline BM26B (DUBBLE) at the ESRF. On BM26B,
measurements on gels were performed as described previously.8
Cell Viability Assays. In vitro cell culture was conducted using
161Br (European Collection of Authenticated Cell Cultures,
ECACC) cells, a human skin ﬁbroblast cell line. Cells were
maintained in a humidiﬁed atmosphere at 37 °C, 5% CO2, and
cultured in EMEM (Eagle’s minimum essential medium), with 2 mM
glutamine, enriched with 15% fetal bovine serum (FBS) and 1%
nonessential amino acids (NEAA).
Potential cytotoxicity eﬀects of RA6R and RA9R were examined
using an MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide) assay. Cells were seeded into a 96-well plate at 4 × 104
cells/mL and allowed to adhere for 24 h in 100 μL of complete
medium. After this, peptides were dissolved in complete medium, and
100 μL of either complete medium or peptide solution was added to
give either control solution (complete medium only) or peptide
solutions with concentrations in the range 0.05−5 mg/mL.
Cells were incubated for 67 h. Following this, 20 μL of MTT (5
mg/mL, in PBS) was pipetted into each well plate and allowed to
incubate for 5 h. After a further 5 h (corresponding to a total of 72 h
treatment), the solution was removed from the wells and replaced
with 100 μL of DMSO per well to dissolve the formazan crystals.
Absorbance was measured as described previously.8
Antimicrobial Assays. The antimicrobial assays were performed
with three types of bacteria, Escherichia coli,38 Staphylococcus aureus,39
and Pseudomonas aeruginosa.40 Culture methods are as described
previously.8
■ RESULTS AND DISCUSSION
We ﬁrst characterize the self-assembly of RA6R and RA9R in
water using CD, FTIR, XRD, SAXS, and cryo-TEM. We then
study the interaction of RA6R and RA9R with model bacterial
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membrane walls represented by DPPG/DPPE multilamellar
vesicles. Finally, we study the cytotoxicity and antimicrobial
activity of RA6R and RA9R. We discuss our results in terms of
the interplay between molecular structure, peptide self-
assembly and biological activity.
Peptide Self-Assembly. ANS and ThT ﬂuorescence
assays were performed to determine the cac for RA6R in
water (Figure S2), as they probe hydrophobic collapse (ANS)
or amyloid ﬁbril formation (ThT).32,41 ANS and ThT assays
provided no evidence of peptide aggregation up to 1 wt %
RA6R since there were no discontinuities in the ﬂuorescence
spectra for either ﬂuorescence probe (Figure S2). In fact, CD,
FTIR, XRD, and SAXS experiments, performed to study the
secondary structure of RA6R in water, indicate that this peptide
does not form deﬁned aggregates.
The CD spectra for (0.5−1) wt % RA6R are characterized by
a broad positive maximum at ∼220 nm and a deep negative
band around 190 nm (Figure 1a) and can be assigned to a
polyproline II (PPII) conformation.20,42−46 The FTIR
spectrum for a 1 wt % sample (Figure 1b) shows bands at
1672 cm−1, 1647 cm−1, 1608 cm−1, and 1587 cm−1, the ﬁrst of
which can be assigned to TFA counterions in solution,47,48 the
1647 cm−1 peak is due to disordered structure, and the latter
two peaks can be assigned to arginine side chain vibrations.49,50
A shoulder peak at 1675 cm−1 is observed for 2 wt % RA6R,
which is characteristic of short peptides with a PPII structure,
in agreement with the CD spectra (Figure 1a).51,52 The XRD
proﬁle (Figure 1c) shows a peak at 4.6 Å corresponding to a
disordered side-to-side packing of the RA6R molecules.
11
SAXS data for RA6R (Figure 1d) show the features of
peptide monomers. The SAXS curves were ﬁtted to a
generalized Gaussian coil model, corresponding to coil-like
molecules in solution with diﬀerent degrees of solvation. The
parameters ﬁtted using the generalized Gaussian model were
the radius of gyration of the peptide Rg and the Flory exponent
ν. Fittings in Figure 1d provided Rg = 7.0 Å, 7.16 Å, 6.94 Å and
ν = 0.64, 0.24, 0.20 for 1, 5, and 15 wt % RA6R, respectively.
This set of parameters implies that RA6R is in a swollen
conformation at 1 wt % and a relatively folded conformation at
5 and 16 wt %. Cryo-TEM images of RA6R solutions show the
formation of occasional clusters of monomers (results not
shown).
The self-assembly of RA9R in water was studied following
the same procedure used for RA6R. Results from the ThT assay
(Figure 2a) shows that RA9R aggregates into amyloid ﬁbers
32
above a cac = (0.18 ± 0.03) wt %. CD shows that the peptide
adopts a predominantly PPII like conformation up to 1 wt %
but at higher concentration forms β-sheet structures (Figure
2b). The PPII structure clearly persists at concentrations above
the cac from the ThT assay. The secondary structure at 1 wt %
remains predominantly PPII like upon heating (Figure S3a),
but changes into a β-sheet conformation, characterized by the
minimum near 216 nm, upon drying the sample (Figure S3b).
The FTIR spectrum for 1 wt % RA9R (Figure 2c) shows peaks
at 1672 cm−1, 1647 cm−1, 1608 cm−1, and 1587 cm−1, which
are respectively assigned to modes associated with TFA
counterions,47,48 disordered structure, and arginine vibrational
modes,49,50 as stated earlier. Upon increasing concentration to
5 wt %, a strong peak develops at 1622 cm−1, which is due to
β-sheet structure.50,53
The XRD proﬁle of RA9R (Figure 2d) shows a 5.32 Å
reﬂection, which can be assigned to the packing of polyalanine
β-sheets,12 with interstrand and intrastrand spacings of 4.32 Å,
3.72 Å, 2.83 Å, 2.39 Å, and 2.26 Å. Interestingly, we observed
that RA9R has the ability to form a weak gel at a concentration
of 5 wt %, which is likely to result from the change in
Figure 1. Conformational and structural characterization of RA6R in solution (a) CD and (b) FTIR spectra; (c) XRD proﬁle; and (d) SAXS
proﬁles. The concentration of the solutions is indicated in the graphs, the full lines in panel d correspond to the ﬁtting of the SAXS data as
described in the text.
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secondary structure from PPII to β-sheet shown by CD. The
properties of the gel will be discussed shortly.
SAXS data measured for 1 wt % RA9R, were modeled using
the form factor of a long cylindrical shell (Figure 2e; ﬁtting
parameters listed in Table S1). The ﬁtted parameters are the
core radius R (with polydispersity ΔR), the shell thickness Dr,
and the scattering length density of the core, shell, and solvent
ηcore, ηshell, and ηsolv. The extracted parameters, R ± ΔR = (15
± 10) Å and Dr = 3 Å, indicate that the cylinder core radius is
less than the length of the oligoalanine A9 sequence = 28.8 Å
(spacing per residue in a parallel β-sheet is 3.2 Å), while the
external shell has a dimension similar to one arginine unit. This
result shows that there is an overlap of the alanine chains
within the core of the ﬁbers, with the arginine residue exposed
at the surface of the ﬁbers. Cryo-TEM conﬁrms the presence of
ﬁbers with an average diameter of 7.6 nm (Figure 2f).
RA9R forms a self-standing gel at 10 and 15 wt %. Figure S4a
shows the SAXS data measured for 15 wt % RA9R along with
the rheological data including the hydrogel linear regime
(Figure S4b) and frequency dependence of the storage (G′)
and loss (G′′) moduli within the linear regime (oscillatory
stress 100 Pa, Figure S4c). The ﬁtting of the SAXS data in
Figure S4a using the same form factor used in Figure 2e
(parameters listed in Table S1) shows that the RA9R hydrogel
comprises a network of ﬁbers similar to those found in
solution.
Overall, our results indicate that, similarly to previously
studied peptide RA3R,
20 RA6R does not self-assemble in water.
It is likely that the ﬂexibility of the PPII helical structure
together with the solubility of the arginine residues does not
favor RA6R self-assembly. Increasing the length of the
hydrophobic central block decreases the solubility of the
molecule and allows for the self-assembly of RA9R into β-sheet
ﬁbrils at suﬃciently high concentration.
Interactions with Liposomes. Next, we examined the
interactions of RA6R and RA9R with a model bacterial mixed
Figure 2. RA9R self-assembly in water: (a) concentration dependence of ThT ﬂuorescence intensity at λem = 520 nm. (b) CD spectra, (c) FTIR
spectra, (d) XRD data, (e) SAXS proﬁles, and (f) cryo-TEM image for a 1 wt % sample above the cac. The concentration of the solutions is
indicated in the graphs. The red line in panel e corresponds to the ﬁtting of the SAXS data as described in the text.
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lipid membrane, represented by DPPG/DPPE vesicles. DPPG
is an anionic lipid, whereas DPPE is zwitterionic and both are
commonly found in bacterial membranes.15,23 We selected
DPPG and DPPE because their melting temperatures (Tm) 41
°C (DPPG) and 63 °C (DPPE) are well apart and can be
accessed with conventional instruments.23 We examined 0.5 wt
% DPPG/DPPE vesicles with ratios 3:1, 1:1, or 1:3, with 0.08
wt % peptide. While 0.08 wt % peptide is in the range of
concentrations used for the antimicrobial assays discussed
below, higher concentrations of peptide led to DPPG/DPPE/
peptide sample precipitation and therefore were excluded from
this study. DSC has been previously used to investigate lipid
demixing in binary lipid membranes, driven by the membrane
interaction with charged peptides.15,23
DSC thermograms for the lipids alone (Figure 3) present
well-deﬁned peaks in the second heating ramps shown (with
the exception of the data for DPPG, which shows a broad
transition for reasons discussed below), as observed
previously.23,54 To compare the inﬂuence of RA6R and RA9R
on the thermotropic phase behavior of the DPPG/DPPE
mixtures, the thermodynamic parameters, namely the main
transition temperature (Tm) and the transition enthalpy ΔH,
were calculated as an indication of the transition cooperativity.
These parameters are listed in Table 1. For DPPE, the Tm stays
within 0.1 °C of the lipid Tm, indicating little peptide binding,
however there is a decrease in ΔH by 23.24 kJ mol−1 and 27.79
kJ mol−1 upon addition of RA6R and RA9R, respectively. This
indicates that there is some interaction between the peptides
and DPPE, which promotes a lowering of the energy needed
for DPPE to undergo the phase transition to the liquid phase.
DPPG alone shows a pretransition to the Pβ ripple phase at
about 35 °C and a main chain melting temperature (to the
ﬂuid state, Lα phase) of 40.5 °C in good agreement with
previous measurements for DPPG.24,55 In the presence of
RA6R, there is a shift in the melting temperature Tm to 52.4 °C,
as expected from peptide binding to anionic lipid.24 RA9R also
causes an increase in the main Tm. A lowering of phase
transition enthalpy is observed for DPPG mixed wityh
peptide, where ΔH is reduced by 8.9 kJ mol−1 and 14.93 kJ
mol−1 for RA6R and RA9R, respectively. The increase in main
transition temperature of 11.9 °C for RA6R and 14.0 °C for
RA9R is likely caused by the charged arginine residues strongly
binding to the anionic DPPG group, causing an increase in the
main transition temperature. Moreover, the peaks for DPPG
with added peptide are asymmetric in shape, with RA9R
showing a small second peak at 50.1 °C, which could be due to
DPPG transitioning in steps into the Lβ phase based on how
much peptide is bound.
For the DPPG/DPPE 3:1 mixtures, there are increases in
main chain transition temperature of 5.5 and 10.6 °C,
respectively, for RA6R and RA9R, which places Tm for RA6R
at a similar value to that observed in the mixture with DPPG
alone, suggesting some demixing could be occurring. The
mixture with RA9R has a higher main transition temperature
than that of DPPG alone. There is an increase in ΔH for both
peptides, indicating that the peptide is stabilizing the Pβ phase.
At a ratio of 1:1 DPPG/DPPE, there are no large changes in
main transition temperature (∼1 °C); however, RA6R shows a
small secondary peak at 60 °C showing evidence of DPPE-rich
regions, which shows demixing may be occurring. Finally, in
the mixtures with 1:3 ratio of DPPG/DPPE, RA9R has an
asymmetric peak with a Tm of 61.5 °C, which is comparable to
that when only DPPE is present, suggesting demixing. RA6R
causes a decrease in transition temperature by 4.6 °C,
suggesting formation of DPPE-depleted domains compared
to the control lipid mixture.
CD was used to examine whether interactions of the
peptides with DPPG/DPPE membranes inﬂuenced their
secondary structure. These measurements were performed at
room temperature, where the lipids are below Tm, that is, in the
gel phase. This is relevant to studying antimicrobial peptide
activity, as highlighted for example by Pimthon et al.30 Figure 4
shows the CD spectra of the RA6R and RA9R (0.08 wt %
peptide), compared to those in the presence of DPPG/DPPE
lipid mixtures. RA6R appears to retain a PPII coil conformation
in the presence of lipids. The decreased molar ellipticity
implies slight loss of structure. The molar ellipticity decreases
with higher ratios of DPPG, and a disordered structure is
observed for the solution of RA6R with only DPPG, which is
characterized by a 190 nm minimum and the loss of the 220
nm broad peak. This is perhaps due to the strong binding
Figure 3. DSC scans showing second heating of DPPG/DPPE lipid
mixtures with or without peptide. Scans for peptides mixed with lipids
are plotted as dashed lines, and data for the lipid mixtures (without
peptide) by the solid lines. The corresponding sample compositions
are indicated in the plots.
Table 1. Maximum Transition Temperature, Tm, and
Enthalpy, ΔH, of Phase Changes Determined from Data
Plotted in Figure 3
mixture Tm (°C) ΔH (kJ mol−1)
DPPE 63.86 37.11
DPPE + RA6R 63.93 13.87
DPPE + RA9R 63.97 9.32
0.5 wt % DPPG/DPPE 3:1 47.13 29.36
0.5 wt % DPPG/DPPE 3:1 + 0.08 RA6R 53.64 38.63
0.5 wt % DPPG/DPPE 3:1 + 0.08 RA9R 57.73 32.24
0.5 wt % DPPG/DPPE 1:1 56.90 30.84
0.5 wt % DPPG/DPPE 1:1 + 0.08 RA6R 56.78 34.61
0.5 wt % DPPG/DPPE 1:1 + 0.08 RA9R 57.80 36.92
0.5 wt % DPPG/DPPE 1:3 60.77 37.52
0.5 wt % DPPG/DPPE 1:3 + 0.08 RA6R 56.19 43.00
0.5 wt % DPPG/DPPE 1:3 + 0.08 RA9R 61.54 37.49
DPPG 40.52 32.43
DPPG + RA6R 52.42 23.53
DPPG + RA9R 54.54 17.50
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between the ionic headgroup of the DPPG and the peptide
inhibiting secondary structure formation.
Remarkably, the PPII secondary structure measured for pure
RA9R in solution changes into a β-sheet structure in the
presence of lipid (Figure 4b). This shows that the DPPG/
DPPE lipid membrane orders the peptide into a β-sheet
secondary structure at a concentration of RA9R below its cac
(Figure 2a). A similar eﬀect has previously been reported by us
for capA6R.
12 The population of RA9R induced β-sheets
increases as the DPPG content increases (Figure 4b),
indicating that RA9R binds more strongly to DPPG than to
DPPE. One possible explanation for the transition to β-sheets
in the presence of the lipid membranes is a local concentration
enhancement of the peptide at the membrane interface since
RA9R does form β-sheet structure, but in bulk only at
concentrations higher than the cac (Figure 2b).
SAXS was also used to examine the interactions of lipids
with the peptides. SAXS data for lipids and peptides shown in
Figure 5 were collected at 20 °C, which is in the gel Lβ phase
for all lipid mixtures. For the pure lipids, a broad peak
positioned at approximately q = 1.5 nm−1 corresponds to
unilamellar vesicles. SAXS data from temperature ramps in the
range 20−50 °C for the peptides mixed with DPPG at two
concentrations are shown in Figure S5, these data show
particularly enhanced lipid bilayer correlations on heating at
the higher peptide concentration studied (0.25 wt %).
Figure 4. CD spectra for (a) RA6R and (b) RA9R peptides on their own or mixed with lipids, at the concentrations indicated.
Figure 5. SAXS proﬁles for mixtures of lipids (total 0.5 wt %) and 0.08 wt % peptide. (a) DPPG:DPPE 1:0, (b) DPPG:DPPE 3:1, (c)
DPPG:DPPE 1:1, (d) DPPG:DPPE 1:3.
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Upon addition of RA9R, the SAXS data in Figure 5 show
that some correlation between bilayers is induced, as indicated
by the presence of small Bragg peaks. In contrast, RA6R only
causes a shift to lower q of the form factor minimum, that is,
there is a slight increase in the bilayer spacing of the
unilamellar vesicles. This implies that RA9R causes membrane
correlations due to the formation of β-sheet structure as
concluded from CD results earlier. However, RA6R does not
change membrane correlations, but it does restructure the
membranes, possibly due to interaction between the arginine
residues and the charged DPPG head groups. In the DPPG/
RA9R mixture, the peptide induces two Bragg peaks with d-
spacing values of 83.1 and 44.8 Å (d = 2π/q0; q0, coordinate for
the peak maxima), consistent with a multilamellar structure.
Cryo-TEM images of peptides in the presence of the lipid
mixtures are shown in Figure S6. These images show the
presence of some ﬁbrils of RA9R coexisting with vesicles;
however, the SAXS signal is dominated by the contribution
from the vesicles, as shown by the data in Figure 5.
Cytocompatibility and Antibacterial Activity. The
results obtained with model DPPG/DPPE membranes suggest
that RA6R has little restructuring eﬀect and may simply be
adsorbed onto the lipid membranes, especially DPPG-rich
ones. On the other hand, RA9R undergoes a conformational
switch in the presence of the gel phase of any of the DPPG/
DPPE composition membranes investigated. These ﬁndings
should be considered in any analysis of the interactions of the
peptides with mammalian and bacterial cells, which have
distinct lipid compositions (bacterial membranes have higher
PE lipid contents).
To assess the cytocompatibility of the peptides, an MTT
assay using human skin ﬁbroblast cells was performed. Cell
Figure 6. MTT assay showing the cytocompatibility of (a) RA6R and (b) RA9R with human skin ﬁbroblasts.
Figure 7. Antimicrobial activity against diﬀerent bacteria, where time 0 is ∼5 min from when the peptide is added to the solution. Peptide
concentrations and bacteria types are indicated in the ﬁgure captions. (a) E. coli, (b) S. aureus, (c) P. aeruginosa, (d) P. syringae.
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viability assays (Figure 6) show that RA6R and RA9R were
tolerated by the cells up to 0.1 and 0.01 wt %, respectively
(above 70% viability). The IC50 concentration was found to be
0.025 wt % for RA9R, while for RA6R, the IC50 was not
observed in the concentration range studied. Since it has been
established that RA6R does not self-assemble, the increase in
cytotoxicity with increasing peptide concentration could be
associated with interactions of the peptide monomer with the
lipid membrane. A similar peptide RA3R also interacts with
lipid membranes in the form of unassociated molecules due to
interactions between the arginine residues and anionic or lipid
head groups.20 The cytotoxicity of RA9R is higher than that of
RA6R at a given concentration, likely in some part due to the
self-assembly of the ﬁbrils, in which the arginine motif is
presented at high density on the ﬁbril surface. A further factor
may be the increased hydrophobicity of RA9R due to the
increase in alanine sequence length.
To investigate the potential antimicrobial activity of these
peptides, a range of common Gram-negative and Gram-
positive bacteria were selected for initial screens using
straightforward bacterial kill assays (counts of colony-forming
units, CFUs). The Gram-positive microbe we selected was S.
aureus, which is commonly found as part of the human
microbiota and is an opportunist pathogen that can cause a
range of infections including food poisoning, skin infections,
and respiratory tract infections. The Gram-negative bacteria we
selected included E. coli, which is a widely studied bacterium
that often causes food-borne infection, and P. aeruginosa, which
is an opportunist pathogen causing serious infections in cystic
ﬁbrosis patients, as well as having advanced multidrug resistant
mechanisms and ability to cause hospital acquired infections
through the formation of bioﬁlms. We also examined P.
syringae, a Gram-negative plant pathogen.
Antimicrobial assays were conducted against these three
strains to assess the survival of E. coli, S. aureus, and P.
aeruginosa in the presence of either control (water), RA6R, or
RA9R. For RA6R, we selected 0.05 and 0.1 wt % as peptide
concentrations because at these concentrations the human cell
viability is 92.5% (±3.4%) and 72.0% (±1.8%), respectively.
For RA9R, we were interested in how the peptide at a
concentration below or above the IC50 concentration aﬀected
antimicrobial activity therefore the concentrations 0.01, 0.05,
and 0.1 wt % were selected. The concentration 0.01 wt % is
much lower than the cac, whereas 0.05 wt % is close to the
concentration at which (according to CD spectra in Figure 4)
the peptide forms a β-sheet structure in the presence of lipid
membranes. The results from the antimicrobial assays are
shown in Figure 7 and Figure S7.
There was no reduction in the bacterial colony count of P.
aeruginosa, E. coli, or S. aureus at an RA9R concentration of
0.01 wt % (Figure S6), showing that there is no antimicrobial
activity under these conditions. When increasing the
concentration to 0.05 wt %, there was a 0.5 log CFU reduction
for E. coli after 24 h (Figure 7a). For S. aureus, there was a
greater reduction of 1 log CFU after 2 h and 1.3 log CFU after
24 h (Figure 7b). For P. aeruginosa and P. syringae, there is no
eﬀect (Figure 7c,d). When increasing the concentration to 0.1
wt % peptide, there is a small, statistically insigniﬁcant
reduction of 0.7 log of E. coli numbers when exposed to
RA9R. Interestingly, the reduction in colony forming units
(CFU) after 24 h are 2.6, 3.4, and 4.0 orders of magnitude for
S. aureus, P. aeruginosa, and P. syringae, respectively. As S.
aureus is a Gram-positive bacterium, and Pseudomonas species
are Gram-negative, this data suggest that RA9R has a broad
range of activity against both classes of bacteria.
For 0.05 wt % RA6R, there is a small reduction in bacterial
colony counts for E. coli and P. aeruginosa after 24 h. At 0.1 wt
% RA6R, there is a more signiﬁcant eﬀect against P. aeruginosa,
denoted by a 4 log reduction in CFU after 24 h. However,
there is no additional eﬀect of 0.1 wt % RA6R on E. coli or S.
aureus. Interestingly, RA6R is also strongly active against P.
syringae with a log 4.5 reduction in CFU after 24 h, suggesting
that RA6R is more active against Pseudomonas bacteria.
For RA6R acting against both E. coli and P. aeruginosa and
RA9R acting against E. coli, the main reduction in the number
of CFUs occurs in the ﬁrst 2 h after treatment with the peptide.
However, in terms of RA9R activity against S. aureus, this
seems to occur steadily over the course of 24 h. The
antimicrobial activity of these peptides is signiﬁcantly lower
than previously studied peptide RA3R,
20 which in part may be
due to the decreased concentrations used in this study, which
were selected to correspond to concentrations where there is
no substantial cytotoxicity. It can be seen that RA9R displays
little antimicrobial activity under these conditions. Interest-
ingly, RA6R displays a strong activity against P. aeruginosa at a
concentration where the cytocompatibility (to ﬁbroblasts) is
acceptable.
■ CONCLUSIONS
We have systematically examined the self-assembly of two
arginine-capped peptide bola-amphiphiles. Peptide RA6R does
not form self-assembled nanostructures, in contrast to RA9R,
which forms ﬁbrils above a critical aggregation concentration,
as imaged by cryo-TEM and as revealed by SAXS form factor
ﬁtting. Remarkably, these ﬁbrils bind the “amyloid” speciﬁc dye
ThT above a cac = 0.18 wt %, although circular dichroism and
FTIR spectroscopy do not indicate β-sheet conformation
below 1 wt % peptide. RA9R does form β-sheet ﬁbrils at high
concentration as indicated by the data in Figure 2b and the CD
spectrum for a dried sample as well as TEM images and SAXS
data. This is also consistent with the observation that it forms a
self-supporting hydrogel at suﬃciently high concentration.
We then studied the interaction of the peptides with model
DPPG/DPPE lipid membranes. DSC shows evidence for
peptide-induced lipid demixing, especially in the DPPG rich
mixtures, consistent with electrostatic interactions between this
anionic lipid and the cationic arginine units in the peptides.
CD spectra indicate no change of peptide conformation for
RA6R in the presence of lipids (PPII conformation retained),
whereas unexpectedly RA9R undergoes a transition to a β-sheet
conformation in the presence of the lipids, possibly due to
enhanced peptide concentration at the membrane interface.
The DSC results suggest no signiﬁcant inﬂuence of the
peptides on Tm (DPPE), suggesting little penetration into the
membrane, although ΔH does change, possibly indicating
adsorption. This eﬀect may be due to the low hydration of PE
membranes resulting from strong lateral interactions of the
lipids in the membrane, driven by hydrogen bonding of the
head groups.56,57 Stronger electrostatic interactions are
expected for DPPG, as previously reported for other cationic
antimicrobial peptides.22,23,25,30,58
Our initial antimicrobial screening study (and corresponding
assay showing low cytotoxicity at the corresponding peptide
concentration) shows that RA6R is a promising antibacterial
agent active against P. aeruginosa, strains of which (including
those that have evolved antimicrobial resistance) can cause
ACS Applied Bio Materials Article
DOI: 10.1021/acsabm.9b00172
ACS Appl. Bio Mater. XXXX, XXX, XXX−XXX
I
serious infections. The enhanced antibacterial activity of RA6R
compared to RA9R may be due to the lower hydrophobicity of
RA6R, which, as we show by CD spectroscopy, also does not
undergo a conformational switch in the presence of lipid
membranes. Peptide RA9R has a longer hydrophobic alanine
sequence and self-assembles above a critical aggregation
concentration and exhibits higher cytotoxicity under con-
ditions where it is aggregated.
These arginine-rich peptide bola-amphiphiles show remark-
able activity toward lipid membranes which is presumed to be
the origin of their antimicrobial properties.
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